Skip to main content

Series B Biopharma Companies

Explore 97 biopharma startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
97
Total Funding
$1.7B
Avg Funding
$67.3M
Cities
23

Export 97 Series B Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Menlo Park, United States
$15.0M
raised

Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$10.0M
raised

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$130.0M
raised

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$254.0M
raised

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Rockville, United States
$50.0M
raised

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Portland, United States
$95.0M
raised

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$67.5M
raised

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Blue Bell, United States
$3.9M
raised

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Saint-antoine, France
$38.9M
raised

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$45.0M
raised

Nuevocor operates as a preclinical-stage biotech company.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Dublin, Ireland
$76.0M
raised

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Houston, United States
$25.0M
raised

Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$70.0M
raised

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$65.0M
raised

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Bothell, United States
$110.0M
raised

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Stockholm, Sweden
$27.3M
raised

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

Jan 2025
Series B

Founder Contacts

41,000+ verified contacts

Sha Tin, Hong Kong

Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$25.0M
raised

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

Oss, The Netherlands
$89.7M
raised

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

New York, United States
$215.0M
raised

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

Nov 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$84.0M
raised

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

Nov 2024
Series B

Founder Contacts

41,000+ verified contacts

Monrovia, United States
$120.0M
raised

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Pohang, South Korea
$5.0M
raised

Bio Design Lab is a biotechnology company that develops biopharmaceutical products.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$32.5M
raised

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$28.9M
raised

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 97 companies

Ready to Connect with Series B Biopharma Startups?

Get verified founder emails, funding details, and company data for 97 series b biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked